Brokerages Set TerrAscend Corp. (OTCMKTS:TRSSF) Target Price at $3.57

TerrAscend Corp. (OTCMKTS:TRSSFGet Rating) has been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $3.57.

Several equities research analysts recently commented on the stock. Canaccord Genuity Group assumed coverage on shares of TerrAscend in a research report on Monday, September 12th. They issued a “buy” rating and a C$4.25 price objective on the stock. Cowen decreased their price objective on shares of TerrAscend from $9.00 to $4.50 in a research report on Monday, August 15th. Stifel Nicolaus decreased their price objective on shares of TerrAscend from C$6.00 to C$5.50 in a research report on Friday, August 12th. Cantor Fitzgerald decreased their price objective on shares of TerrAscend from $2.85 to $2.15 and set a “neutral” rating on the stock in a research report on Friday, October 28th. Finally, Craig Hallum lowered shares of TerrAscend from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $7.50 to $2.00 in a research report on Friday, August 12th.

TerrAscend Price Performance

Shares of OTCMKTS TRSSF opened at $1.78 on Tuesday. The firm has a market capitalization of $448.31 million and a P/E ratio of -1.33. TerrAscend has a one year low of $1.21 and a one year high of $6.76. The company’s fifty day moving average is $1.55 and its two-hundred day moving average is $2.29. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.37 and a current ratio of 0.66.

TerrAscend Company Profile

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania.

Featured Stories

Analyst Recommendations for TerrAscend (OTCMKTS:TRSSF)

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.